Last reviewed · How we verify

NCT04968041

KNA Proof-of-Concept

Completed NA Results posted Last updated 1 March 2024
What this trial tests

NA trial testing Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program in Adherence, Treatment in 10 participants. Completed in 30 August 2020.

Timeline
27 September 2019
Primary endpoint
30 June 2020
30 August 2020

Quick facts

Lead sponsorFlorida State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment10
Start date27 September 2019
Primary completion30 June 2020
Estimated completion30 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida State University

Who can join

Adults 60 to 75, any sex, with Adherence, Treatment or Retention. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Ketogenic Adherence Primary · 6-weeks

Assessed based on reported ketone levels during the program (reporting at least one day or greater with trace amounts of ketones) using urinalysis ketone test strips administered at home by participants.

GroupValue95% CI
MI-CBT KNA Program8
Acceptability Primary · 6-weeks

Assessed based on qualitative feedback and online surveys described here: https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-022-00970-z. Participants also rated how well they felt the program helped them achieve their health-related goals 0 (none) to 3 (all).

All goals
GroupValue95% CI
MI-CBT KNA Program3
Most
GroupValue95% CI
MI-CBT KNA Program1
Some
GroupValue95% CI
MI-CBT KNA Program5
Retention Primary · baseline to 6-weeks

Assessed based on attendance and % of participants who remained in the program from start to finish

GroupValue95% CI
MI-CBT KNA Program9
Cognitive Functioning Secondary · Baseline and 6-weeks

Assessed using the total scaled score (age-normed) of the Repeatable Battery for the Assessment of Neuropsychological Status - Update. A score of 100 is considered "average" (50th percentile), and higher scores are considered better cognitive functioning. The outcome reported is the actual value at 6-weeks, rather than a change score.

GroupValue95% CI
MI-CBT KNA Program97.11± 11.14

Sponsor's own description

The intervention program proof-of-concept was assessed as a single-arm, within-subjects clinical study with a target enrollment of 10 participants with possible or probable amnestic MCI. The protocol required participants to complete a pre-intervention assessment within two weeks of beginning the intervention, attend seven, one-hour intervention group sessions across six weeks, complete a post-assessment and interview in the final week of the intervention, and complete weekly surveys throughout the intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Ketone Supplementation: Meeting the Needs of the Brain in an Energy Crisis.
    Poff AM, Moss S, Soliven M, D'Agostino DP. · · 2021 · cited 34× · PMID 35004814 · DOI 10.3389/fnut.2021.783659
  2. Feasibility of an MI-CBT ketogenic adherence program for older adults with mild cognitive impairment.
    Sheffler JL, Arjmandi B, Quinn J, Hajcak G, et al · · 2022 · cited 5× · PMID 35065656 · DOI 10.1186/s40814-022-00970-z

Verify or expand the search:

Other trials of Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program

Trials testing the same drug.

Other recruiting trials for Adherence, Treatment

Currently open trials in the same condition.

Other Florida State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04968041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing